超声显示单个异常淋巴结与多个异常淋巴结的乳腺癌患者腋窝肿瘤负荷比较
这项前瞻性多中心队列研究纳入123例术前腋窝超声(AUS)穿刺活检证实淋巴结阳性并接受腋窝淋巴结清扫(ALND)的早期乳腺癌患者,比较AUS显示单个与多个异常淋巴结者的组织学阳性淋巴结数。肿瘤≤20 mm且AUS仅一个异常淋巴结者中约78%在ALND时阳性淋巴结≤2个,该组合预测≥3个转移的敏感度为95%、特异度为35%。作者认为这些患者接受初始ALND属于过度治疗,可提供前哨淋巴结活检(SNB)。
要点
- AUS显示单个异常淋巴结且肿瘤≤20 mm者,78%在ALND时阳性淋巴结≤2个。
- 该组合预测≥3个转移的敏感度95%、特异度35%、阳性预测值75%、阴性预测值78%。
- 肿瘤≤20 mm与AUS单个异常淋巴结均与ALND时阳性淋巴结≤2个相关(均p<0.001)。
核心结论
- 在穿刺活检证实淋巴结阳性的早期乳腺癌患者中,约四分之三(78%)浸润性肿瘤≤2 cm且AUS仅一个异常淋巴结者在ALND时阳性淋巴结≤2个。
- 作者认为这些患者接受初始ALND属于过度治疗,可提供前哨淋巴结活检(SNB)。
研究设计与样本
- 前瞻性多中心队列研究,2015年10月至2016年7月连续纳入AUS穿刺活检证实淋巴结阳性并接受ALND的早期乳腺癌患者123例。
- 术前AUS异常淋巴结数由乳腺放射科医生或放射技师记录,以ALND组织学阳性淋巴结数为参考标准。
- 患者中位年龄62岁(范围30–93岁)。
关键影像表现/征象
- AUS显示单个异常淋巴结者54/123(44%),多个异常淋巴结者69/123(56%)。
- ALND后组织学显示阳性淋巴结≤2个者40/123(33%)。
诊断标准与关键数值
- 肿瘤≤20 mm(p<0.001)和AUS单个异常淋巴结(p<0.001)均与ALND时阳性淋巴结≤2个相关,两者在logistic回归分析中均保持显著。
- 基于肿瘤≤20 mm与AUS单个异常淋巴结两因素组合预测至少3个转移:敏感度95%(79/83),特异度35%(14/40),阴性预测值78%(14/18),阳性预测值75%(79/105)。
临床应用与阅片要点
- 对AUS穿刺活检证实淋巴结阳性、浸润性肿瘤≤2 cm且AUS仅一个异常淋巴结的患者,作者认为可提供前哨淋巴结活检(SNB)。
- 作者认为上述患者接受初始ALND属于过度治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To determine if the number of abnormal nodes seen on preoperative axillary ultrasound (AUS) is a predictor of the number of positive nodes at histology for women with needle-biopsy-proven positive nodes.
MATERIALS AND METHODS: This prospective multicentre cohort study included consecutive patients with early breast cancer who had needle-biopsy-proven positive nodes on AUS and underwent axillary lymph node dissection (ALND) between October 2015 and July 2016. The number of abnormal nodes at preoperative AUS was recorded by breast radiologists or radiographers.
RESULTS: One hundred and twenty-three patients were included in the study. The median age of the women was 62 (range 30-93) years. Fifty-four of the 123 (44%) women had one abnormal node, whereas 69 (56%) had multiple abnormal nodes on AUS. Forty of the 123 (33%) women had two or fewer nodes with metastases at histology after ALND. Tumours ≤20 mm (p<0.001) and one abnormal node on AUS (p<0.001) were associated with two or fewer nodes with metastases at ALND. Both remained significant in logistic regression analysis. The likelihood of at least three metastases based on the combination of these two factors had 95% sensitivity (79 of 83), 35% specificity (14 of 40), a negative predictive value of 78% (14 of 18), and a positive predictive value of 75% (79 of 105).
CONCLUSION: Among women with needle-biopsy-proven positive nodes, around three in four women (78%) with an invasive tumour ≤2 cm and one abnormal node on AUS have two or fewer positive nodes at ALND. These women are overtreated by upfront ALND and can be offered sentinel node biopsy (SNB).
引用
- Puri S, Sharma N, Newcombe RG, et al. Axillary tumour burden in women with one abnormal node on ultrasound compared to women with multiple abnormal nodes. Clin Radiol. 2018. PMID: 29352595. doi:10.1016/j.crad.2017.12.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。